Oleoylethanolamide increases the expression of PPAR-Α and reduces appetite and body weight in obese people: A clinical trial
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trialLipids in Health and Disease, 2012
- Lifestyle Modification for ObesityCirculation, 2012
- N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegansNature, 2011
- Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neuronsInternational Archives of Medicine, 2011
- Reward, dopamine and the control of food intake: implications for obesityTrends in Cognitive Sciences, 2011
- Fatty acid amide signaling moleculesBioorganic & Medicinal Chemistry Letters, 2010
- Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 ChannelsNeuropsychopharmacology, 2008
- Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)Journal of Biological Chemistry, 2004
- Oleoylethanolamide inhibits food intake in free-feeding rats after oral administrationPharmacological Research, 2004
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000